All Announcements

Weil advises Providence Equity in $400M acquisition of shares of OUTFRONT Media

Weil is advising Providence Equity Partners as lead investor, together with Ares Management, in a $400 million acquisition of convertible preferred shares of OUTFRONT Media, Inc., a publicly traded provider of outdoor advertising services. The transaction is subject to customary closing conditions.

Read More

Weil wins dismissal of stockholder derivative action against lululemon regarding CEO misconduct

April 2, 2020, Weil won a decisive victory for the Board of Directors of global retailer lululemon athletica inc. in a stockholder derivative complaint alleging that the company’s former CEO – in plaintiff’s words – “created a toxic culture at lululemon and engaged in a pattern of sexual harassment and sexual favoritism while CEO.” The Delaware Court of Chancery’s 39-page opinion granted the Board’s motion to dismiss the action in its entirety.

Read More

Steven A. Reiss to receive ABA John H. Pickering Achievement Award

Retired partner Steven A. Reiss will receive the American Bar Association’s 2020 John H. Pickering Achievement Award in recognition of his legal work, dedication to pro bono service and the community, and significant contributions to the furtherance of access to justice for all. He will be honored at a reception and dinner in Washington, D.C. on April 22.

Read More

Weil advises Front Yard Residential in its $2.3B sale to Amherst Residential

Weil is advising Front Yard Residential Corporation, a REIT that acquires, owns and manages single-family rental properties throughout the United States, in its $2.3 billion sale to Amherst Residential, LLC, a vertically-integrated provider of high-quality and affordable rental homes. The transaction is expected to close in the second quarter of 2020, subject to customary closing conditions.

Read More

Weil advises Eli Lilly in its $1.1B acquisition of Dermira

Weil is advising Eli Lilly and Company in its pending $1.1 billion acquisition of Dermira, Inc., a developer of new therapies for chronic skin conditions. The transaction is expected to close in the first quarter of 2020 subject to customary closing conditions.

Read More

Weil advises Graycliff partners in $350M buyout fund

Weil advises Graycliff Partners in its formation of Graycliff Private Equity Partners IV LP, a private buyout fund focused on North American manufacturing, business services and value-added distribution businesses. The oversubscribed fund closed at its hard cap of $350 million in limited partner commitments.

Read More

Weil advises Cornell Capital and KDC/ONE

Weil is advising Cornell Capital and its portfolio company Knowlton Development Corporation (KDC/ONE), a contract developer, manufacturer and supplier of personal care and household products, in its merger with HCT Group Holdings Limited, a provider of design, engineering, manufacturing, formulation, filling and logistics services for cosmetics products.

Read More